The Mullings Group Archives - Medical Design Sourcing

The Mullings Group acquires M. J. Moore & Associates and names Michael Moore partner

NEWS RELEASE: The Mullings Group acquires M. J. Moore & Associates and names Michael Moore partner

Delray Beach, Florida (Nov. 1, 2023) – The Mullings Group, a leading talent acquisition firm headquartered in the U.S. specializing in medical & health technology, life sciences, and emerging high-tech industries, announces the acquisition of M. J. Moore & Associates. The founder of M. J. Moore & Associates, Michael Moore, will join the TMG team as a partner and continue building companies and careers within our industries.

TMG has over three decades of building companies and careers and is the industry’s largest and most successful search firm in the MedTech/HealthTech market, with offices in the U.S., Canada, the U.K., and APAC. The search firm is responsible for more than 8,000 successful searches with over 800+ clients ranging from multi-billion-dollar companies to emerging tech startups worldwide.

Mike has spent the past 25 years working…

Artificial intelligence: What medtech’s top influencers think

Artificial intelligence’s effect on medtech was a question that came up continually during our DeviceTalks Boston show in early May.

Here is what some of the top influencers in the industry had to say:

Boston Scientific CEO Mike Mahoney [Photo courtesy of Boston Scientific]

Boston Scientific CEO Mike Mahoney on artificial intelligence and medtech

“I’ll give you some practical applications. … We have manufacturing plants around the world, and we have great quality systems, and we have great quality engineers who inspect everything, and we have a zillion microscopes looking at every little product that we have all over the world. Our team is leveraging AI capabilities for visualization inspection rather than the human eye constantly doing that with the mistakes that are inherent and scrapping products and so forth. … We’re seeing cost productivity and better quality by just leveraging AI in our…

They said it at DeviceTalks Boston 2023

Medical device industry leaders from Boston Scientific, Abbott, ZimVie, Medtronic, Stryker and more met at DeviceTalks Boston to share lessons learned and their perspectives on industry trends, device design and medtech innovation.

BD Chair, CEO and President Tom Polen (right) at DeviceTalks Boston with DeviceTalks Editorial Director Tom Salemi [Photo by Jeff Pinette for Medical Design & Outsourcing]

Bidding farewell to DeviceTalks Boston 2023, we look back at an exceptional two-day medical device conference teeming with insights from over 100 top industry leaders.

These experts unfolded many complexities of the medtech industry in more than 35 sessions, walking attendees from the medical device product development continuum through the latest medical innovations and strategies to tackle regulatory challenges, prototyping, manufacturing, product launches and more.

Between the high-profile keynote int…

What could medtech lose from the Silicon Valley Bank shutdown?

A host of medtech companies dodged the loss of billions of dollars in Silicon Valley Bank deposits — but the space still faces challenges.

That is one of the big takeaways from the latest DeviceTalks Weekly podcast.

The FDIC shuttered Silicon Valley Bank on March 10 to stave off a bank run amid depositor concerns over how the bank had managed risk around rising interest rates. With $209.0 billion in total assets and about $175.4 billion in total deposits, it was the second-largest bank collapse in U.S. history.

Silicon Valley Bank was a huge name in the tech and startup world since its founding in the 1990s. SVB’s website said half of all U.S. VC-backed tech and life science companies used the Santa Clara, California–based bank. Especially vulnerable were startups and other young companies that parked their funds at the bank — and found themselves asking how much they’d get back above the $250,000 FDIC deposit insurance limit.

By Sunday, March 12,…

DeviceTalks Weekly: Ep. 9 – What’s the state of the medtech job market?

In this week’s episode of DeviceTalks Weekly, Tom Salemi speaks with two executive recruiters about what they see in the medtech market. Over the past month, we’ve seen several medtech companies – big and small – cutting jobs and reducing hours but what does this mean long-term.

In this podcast we’ll identify a few companies that are hiring, but we’ll talk in-depth with the recruiters about…

How bad is the current market? What’s the likelihood for recovery? What skills are in greater demand? What can people do to strengthen their hand?

Guests are:

David L. Vied, global sector leader, Global Sector Leader, Medical Devices and Diagnostics, Korn Ferry Giovanni Lauricella, VP, medtech practice-lead, The Mullings Group

Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.